Azienda Ospedaliera Universitaria Pisana
(Data Parere Unico CE 22-04-2020)
-
Formazione
-
Protocolli Covid-19
- BARICIVID-19 STUDY:MultiCentre, randomised, Phase IIa clinical trial evaluating efficacy and tolerability of Baricitinib as add-on treatment of patients with COVID-19 compared to standard therapy -
BARICIVID-19 STUDY:MultiCentre, randomised, Phase IIa clinical trial evaluating efficacy and tolerability of Baricitinib as add-on treatment of patients with COVID-19 compared to standard therapy -
BARCIVID documentiSIMIT – Società Italiana di Malattie Infettive e Tropicali- Via del Romito 63/A - 59100 Prato (PO) - Partita I.V.A. e C.F. 01440750154
Certificata ISO 9001:2015 - Normativa Privacy
Sito realizzato da B&S immagine e comunicazione